Biggest News Aggregation in the World
📰 Pascal Hickey News

Pascal Hickey News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Pascal Hickey. Real-time updates on events, politics, business and more.

Aravax doses first patient in Phase 2 peanut allergy clinical trials

MELBOURNE, Australia, June 1, 2023 /PRNewswire/ --The first patient has been dosed in a Phase 2 study (AVX-201) being run by biotechnology company Aravax, which is developing the novel therapy PVX108 for the safe and convenient treatment of peanut allergy. The study is being conducted under a U.S. FDA Investigational New Drug Application. Allergy clinical trial centres across Victoria, South Australia, New South Wales, and Western Australia have invited children and adolescents aged four to 17 y...
United States Ciara Byrne Sara Prickett Kirsten Perrett Pascal Hickey Murdoch Children Research Institute

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science